InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
4
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-21.6%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Douglas Richard, 董事. Insider active across 3 companies, notably NOVAVAX INC. In total, 14 filings have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €696k. Activity tracked since 22 November 2021. The latest transaction was disclosed on 19 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Douglas Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
18,880 股Common StockSEC:0001104659-26-076927:0
30,421 股Common StockSEC:0000905148-26-003053:0
70,000 股@ US$1.40100.0% 占其流量Common StockSEC:0001193125-26-117675:0
标准退出：2026年6月17日 (T+90)
80,000 股@ US$1.38815.5% 占其流量Common StockSEC:0000905148-25-002874:0
标准退出：2025年11月11日 (T+90)
29,210 股0Common StockSEC:0000905148-25-002232:0
10,420 股0Common StockSEC:0001593968-25-000757:0
6,670 股0Common StockSEC:0001593968-24-000863:0
21,367 股0Common StockSEC:0001415889-24-016715:0
3,100 股Common StockSEC:0001209191-23-036744:0
80,000 股@ US$4.318544.7% 占其流量Common StockSEC:0001209191-23-021573:0
标准退出：2023年6月27日 (T+90)
700 股Common StockSEC:0001209191-22-038592:0
1,500 股@ US$25.60100.0% 占其流量Common StockSEC:0001209191-21-069798:0
20,000 股@ US$11.1232.3% 占其流量Common StockSEC:0001209191-21-066289:0
标准退出：2022年2月20日 (T+90)
3,450 股Common StockSEC:0001209191-21-043700:0
14 条申报中的 14 条
About Douglas Richard
DOUGLAS RICHARD is Administrateur at NOVAVAX INC, Maxcyte, INC. and Aldeyra Therapeutics, Inc. He has 14 filings in total, and across the recent sampled filings held, purchases amount to EUR 696122 and sales to EUR 0, over the period from 2021-06-29 to 2026-06-23. The modal transaction nature is Levée d'options.
